This document summarizes tetanus, including its pathophysiology, clinical types, features, management, prophylaxis and immunity. Tetanus is caused by Clostridium tetani toxin affecting the nervous system and causing muscle spasms. It enters through wounds and produces toxin. Management focuses on wound care, controlling spasms, and neutralizing toxin. Prophylaxis includes tetanus toxoid vaccination and immunoglobulin for wounds at risk of tetanus infection. Both active and passive immunity can be developed to prevent tetanus.
The presentation deals with the basics of hemorrhage i.e. classification, etiology. It also covers the mechanism of hemostasis and the various methods to achieve hemostasis.
Hope you like it! Suggestions and feedback will always be well appreciated. :)
This presentation mainly deals with granuloma formation and various factors involved in it. It describes the examples of granulomatous disorders and gives a details on how to seperate them on histopathology.It also describes type 4 hypersensitivty reaction concisely
The presentation deals with the basics of hemorrhage i.e. classification, etiology. It also covers the mechanism of hemostasis and the various methods to achieve hemostasis.
Hope you like it! Suggestions and feedback will always be well appreciated. :)
This presentation mainly deals with granuloma formation and various factors involved in it. It describes the examples of granulomatous disorders and gives a details on how to seperate them on histopathology.It also describes type 4 hypersensitivty reaction concisely
What is immunization & national EPI schedule.
What is tetanus toxoid & history of tetanus toxoid vaccine.
What is ATS and its uses.
What is dose and mechanism of action of TT vaccine.
What is the Immunization schedule of TT and side effects of vaccine.
What is site of administration of vaccine and its Booster dose.
What are the positions of patients given during hospital stay.
Defining the patients positions as well as their risks.
Tetanus, Lock Jaw, Opisthotonus, Tetanus Immunoglobulins, Immunization, Cephalic Tetanus. A much feared topic among residents explained in a simple way.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
3. Introduction to tetanus
Pathophysiology
Clinical types
Clinical features
Management
Tetanus prophylaxis
Types of immunity
4. Is an acute infectious disease caused by toxin
producing anaerobe clostridium tetani that
commonly found in soil, saliva, dust, and
manure.
Produce a toxin that affect the brain and
nervous system, leading to spasm and
stiffness in the muscles.
5. Apparently trivial injuries
Animal bites
Open fractures
Burns
Gangrene
In neonates usually via infected umbilicus
Abscess
6. 1
• C. Tetani enters the body through the contaminated wounds.
2
• Stays in spore form until anaerobic condition presented.
3
• Germinate under anaerobic conditions and begin to multiply and produce
tetanospasmin.
4
• Tetanospasmin spread and binds to motor neurons.
5
• Travels along the axons to the spinal cord.
6
• Binds to site responsible for inhibiting muscle contraction, and blocks the
release of inhibitory neurotransmitters
7.
8. • Most common and severe form
affects all skeletal muscles.
Generalized
• Manifest with muscle spasm at or
near the infected wound.
Local
• Affect one or more muscles in face in one or
two days after a head injury or ear infection.
•Lockjaw occur that can easily progress
to generalized tetanus.
Cephalic
• Similar to generalized tetanus and
affects the neonates.
Neonatal
9. Risus sardonicus: Contraction of the muscles
at the angle of mouth and frontalis.
Trismus: also called lockjaw is the spasm of
Masseter muscles.
Opisthotonus: spasm of extensor of the neck,
back and legs to form a backward curvature.
Tetany: Prolonged muscular action causes
sudden, powerful, and painful contraction of
muscle groups.
10. If respiratory muscles involved ---Apnea
Drooling
Excessive sweating
Fever
Hand or foot spasm
Irritability
Swallowing difficulty
Uncontrolled urination or defecation.
14. General measure
Goal is to eliminate the source of toxin.
Admit in a dark and quiet room in ICU.
Continuous careful observation and
cardiopulmonary monitoring.
minimize stimulation.
Protect airway.
Wound management
wound should be cleaned and necrotic and
foreign material should be removed.
15. wound is then lightly bandaged to prevent
formation of local anaerobic environment.
Control of spasm
Minimize the stimuli.
Anticonvulsants.
Sedatives
Muscle relaxants
Neutralize the remaining unbound toxin
HTIG/ATS
Elimination of C. tetani
Penicillin G, Metronidazole.
16. Tetanus prophylaxis depend on the nature
of the lesion and patient’s immunization
history it may include tetanus
immunoglobulin (TIG) and tetanus toxoid
(TT) containing vaccines.
The emergency department patient
encounter provide an ideal opportunity to
screen the patient for adequate tetanus
immunization and provide it when
necessary.
17. Patient seen in emergency department with
clean, minor wounds are considered adequately
immunized if they have received primary
immunization and have had a booster shot within
the past 10 years.
And if a wound is dirty (which includes wound
contaminated with saliva, feces or dirt, and burn
injuries) then a booster within the 5 years is
necessary to ensure immunization. If the patient
has not received primary immunization or unsure
then passive immunity with TIG is provided.
18. A wound sustained more than 6 hours before
surgical treatment
Deeper than 1cm
Soil, feces contamination
Burns, missiles, crush, frostbites and animal
bites
Devitalized tissues
Puncture or penetrating wounds
Infected cord in neonates
Surgical incision contamination
19.
20. Tetanus is completely preventable disease by
active tetanus immunization.
Tetanus vaccine is a component of Expanded
program on immunization(EPI).
Begin in infancy with DTP series of shot.
21. Active immunization
1st dose at 6th week (DPT)
2nd dose at 10th week (DPT)
3rd dose at 14th week (DPT)
1st booster at 18th week(DPT)
2nd booster at 6th year (DT)
3rd booster at 10th year (TT)
Duration of active immunity is 5 years after primary
series . Dose is 0.5ml IM
22. Passive immunization
1. Tetanus immunoglobulin(TIG) It is used for
prophylaxis and therapy.
provide protection for 30 days
Prophylactic dose is 250 IU IM and
therapeutic dose is 1000 – 10000 IU IM.
2. Teatnus Antitoxin serum (ATS) Protection last for
7 - 15 days.
prophylactic dose is 1500 – 3000 IU IM therapeutic
dose is in neonate is 10000 IU S/C, IM, IV and in
children is 40000 – 60000 IU(half IM and half IV).
23. Immunity is the ability of the body to protect
against all types of foreign bodies like
bacteria, virus, toxic substances that enters
the body.
Immune response is the reaction of the body
against any foreign antigen.
24. 1.Innate immunity:
It is also called natural or native immunity, consist of
mechanism that exist before infection and are capable of rapid
responses to microbes.
It comprise of 4 types of defense barriers
Anatomical barriers
Physiologic barriers.
Phagocytic barriers.
Inflammatory barriers.
25.
26. Acquired immunity
Also called adaptive immunity is the immunity that
is developed by the host in its body after exposure to
suitable antigen or after a transfer of anti bodies or
lymphocyte from an immune donor.
Characteristic of acquired immunity
Antigenic specificity
Diversity
Immunologic memory
Self/non self recognition
27. 1. Active immunity
it is induced by natural exposure to a
pathogen or by vaccination.
2. Passive immunity
Achieved by transfer of immune products
such as antibody or sensitized T cells from
an immune individual to non immune one.